Medical Science Liaison Institute at http://www.MSLmetrics.com), has found that companies still need to tighten their understanding of this field in order to benefit from the valuable expertise of their MSLs. “MSLs are the main point of contact for thought leaders who are at the cutting edge of research and have a defining influence on healthcare standards,” explains Jane Chin Ph.D., President of Medical Science Liaison Institute LLC. “This means that MSLs can provide pharmaceutical companies with a wealth of valuable information for their activities.” The new report, entitled “Medical Science Liaison Performance Metrics” examines organizational models, factors driving medical science liaison activities, performance metrics models, and MSL program constituents’ views on value and metrics. Performance metrics maintain the visibility of medical science liaisons in the pharmaceutical organization and help communicate the value of medical science liaisons in the organization.
